Cheng, C.-Y.; Haque, A.; Hsieh, M.-F.; Imran Hassan, S.; Faizi, M.S.H.; Dege, N.; Khan, M.S.
1,4-Disubstituted 1H-1,2,3-Triazoles for Renal Diseases: Studies of Viability, Anti-Inflammatory, and Antioxidant Activities. Int. J. Mol. Sci. 2020, 21, 3823.
https://doi.org/10.3390/ijms21113823
AMA Style
Cheng C-Y, Haque A, Hsieh M-F, Imran Hassan S, Faizi MSH, Dege N, Khan MS.
1,4-Disubstituted 1H-1,2,3-Triazoles for Renal Diseases: Studies of Viability, Anti-Inflammatory, and Antioxidant Activities. International Journal of Molecular Sciences. 2020; 21(11):3823.
https://doi.org/10.3390/ijms21113823
Chicago/Turabian Style
Cheng, Ching-Yi, Ashanul Haque, Ming-Fa Hsieh, Syed Imran Hassan, Md. Serajul Haque Faizi, Necmi Dege, and Muhammad S. Khan.
2020. "1,4-Disubstituted 1H-1,2,3-Triazoles for Renal Diseases: Studies of Viability, Anti-Inflammatory, and Antioxidant Activities" International Journal of Molecular Sciences 21, no. 11: 3823.
https://doi.org/10.3390/ijms21113823
APA Style
Cheng, C.-Y., Haque, A., Hsieh, M.-F., Imran Hassan, S., Faizi, M. S. H., Dege, N., & Khan, M. S.
(2020). 1,4-Disubstituted 1H-1,2,3-Triazoles for Renal Diseases: Studies of Viability, Anti-Inflammatory, and Antioxidant Activities. International Journal of Molecular Sciences, 21(11), 3823.
https://doi.org/10.3390/ijms21113823